UPMC studies Covid-19 vaccine effectiveness in immunocompromised, seniors

Two new studies from the University of Pittsburgh School of Medicine and UPMC are getting at the effectiveness of Covid-19 vaccines in immunocompromised and vulnerable populations, with good news about how well the vaccine does in seniors who live in long-term care facilities but warnings about the effectiveness in people with some types of cancer. Researchers said Friday that there's increasing signs that efficacy of Covid-19 vaccines in people with blood, bone marrow or lymph node cancer don't…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news